Production of DHA and other LC PUFAs in plants

US10669554B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10669554-B2
Application numberUS-201715825107-A
CountryUS
Kind codeB2
Filing dateNov 29, 2017
Priority dateMay 17, 2010
Publication dateJun 2, 2020
Grant dateJun 2, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides recombinant host organisms (e.g., plants) genetically modified with a polyunsaturated fatty acid (PUFA) synthase system and one or more accessory proteins (e.g., PPTase and/or ACoAS) that allow for and/or improve the production of PUFAs in the host organism. The present invention also relates to methods of making and using such organisms (e.g., to obtain PUFAs) as well as products obtained from such organisms (e.g., oil and/or seed).

First claim

Opening claim text (preview).

The invention claimed is: 1. A genetically modified Brassicaa napus plant that comprises a seed oil comprising 0.01% to 5% by weight of eicosapentaenoic acid (EPA), the genome of the plant comprising: a first polynucleotide encoding the polyunsaturated fatty acid (PUFA) synthase system polypeptide of SEQ ID NO:1, wherein the nucleotide sequence of the polynucleotide has been codon-optimized according to the codon usage of B. napus , and wherein the nucleotide sequence is at least 80% identical to SEQ ID NO:6; a second polynucleotide encoding the PUFA synthase system polypeptide of SEQ ID NO:2, wherein the nucleotide sequence of the polynucleotide has been codon-optimized according to the codon usage of B. napus , and wherein the nucleotide sequence is at least 80% identical to SEQ ID NO:7; a third polynucleotide encoding the PUFA synthase system polypeptide of SEQ ID NO:3, wherein the nucleotide sequence of the polynucleotide has been codon-optimized according to the codon usage of B. napus , and wherein the nucleotide sequence is at least 80% identical to SEQ ID NO:8; a fourth polynucleotide encoding the phosphopantetheinyl transferase (PPTase) polypeptide of SEQ ID NO:5, wherein the nucleotide sequence of the polynucleotide has been codon-optimized according to the codon usage of B. napus , and wherein the nucleotide sequence is at least 80% identical to SEQ ID NO: 10; and a fifth polynucleotide encoding the acyl-CoA synthetase (ACoAS) of SEQ ID NO:4, wherein the polynucleotide is codon-optimized according to the codon usage of B. napus , and wherein the nucleotide sequence is at least 80% identical to SEQ ID NO:9, wherein each of the first, second, third, fourth, and fifth polynucleotides is operably linked to a seed-specific promoter that is functional in B. napus. 2. The genetically modified Brassica napus plant of claim 1 , wherein all of the polynucleotides are contained in a single recombinant genomic insert. 3. The genetically modified Brassica napus plant of claim 1 , wherein each of first, second, third, fourth, and fifth polynucleotides is operably linked to Phaseolus vulgaris phytohemagglutinin-L (PvDlec2) promoter. 4. The genetically modified Brassica napus plant of claim 1 , further comprising a Brassica -optimized polynucleotide encoding an acetyl CoA carboxylase (ACCase) or a polynucleotide encoding a type 2 diacylglycerol acyltransferase (DGAT2). 5. The genetically modified Brassica napus plant of claim 1 , wherein the seed oil further comprises 0.01% to 15% by weight of docosahexaenoic acid (DHA) or 0.01% to 5% by weight docosapentaenoic acid (DPA). 6. A plant cell of the genetically modified Brassica napus plant of claim 1 , wherein the plant cell comprises the first, second, third, fourth and fifth polynucleotides. 7. A plant material of the genetically modified Brassica napus plant of claim 1 , wherein the plant cell comprises the first, second, third, fourth and fifth polynucleotides. 8. The plant material of claim 7 , wherein the plant material is a B. napus tissue or a seed comprising the first, second, third, fourth and fifth polynucleotides. 9. A method to produce a canola oil comprising 0.01% to 5% by weight of eicosapentaenoic acid (EPA), the method comprising recovering oil from the genetically modified Brassica napus plant of claim 1 . 10. A method for producing the genetically modified Brassica plant of claim 1 , the method comprising transforming a Brassica napus plant material with the first, second, third, fourth and fifth polynucleotides. 11. The method according to claim 10 , wherein the B. napus plant material is transformed with a single vector comprising all of the first, second, third, fourth and fifth polynucleotides. 12. The genetically-modified Brassica napus plant of claim 1 , wherein the methionine residue at the first amino acid position of at least one of the polypeptides encoded by the polynucleotides is replaced with a chloroplast transit peptide (CTP). 13. The genetically modified Brassica napus plant of claim 12 , wherein the CTP is selected from the group consisting of ribulose bisphosphate carboxylase small chain 1A CTP. 14. The genetically modified Brassica napus plant of claim 12 , wherein the CTP is encoded by SEQ ID NO:11.

Assignees

Inventors

Classifications

  • Transferases for other substituted phosphate groups (2.7.8) · CPC title

  • transferring groups other than amino-acyl groups (2.3.1) · CPC title

  • involving modified lipid metabolism, e.g. seed oil composition · CPC title

  • Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone · CPC title

  • Nutrients, e.g. vitamins, minerals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10669554B2 cover?
The invention provides recombinant host organisms (e.g., plants) genetically modified with a polyunsaturated fatty acid (PUFA) synthase system and one or more accessory proteins (e.g., PPTase and/or ACoAS) that allow for and/or improve the production of PUFAs in the host organism. The present invention also relates to methods of making and using such organisms (e.g., to obtain PUFAs) as well as…
Who is the assignee on this patent?
Dow Agrosciences Llc, Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification C12N15/8247. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).